GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (XSAT:DANCAN) » Definitions » Inventories, Other

DanCann Pharma AS (XSAT:DANCAN) Inventories, Other : kr0.00 Mil (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is DanCann Pharma AS Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. DanCann Pharma AS's other inventories for the quarter that ended in Dec. 2024 was kr0.00 Mil.


DanCann Pharma AS Inventories, Other Historical Data

The historical data trend for DanCann Pharma AS's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DanCann Pharma AS Inventories, Other Chart

DanCann Pharma AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial - - - - -

DanCann Pharma AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

DanCann Pharma AS Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


DanCann Pharma AS Business Description

Traded in Other Exchanges
N/A
Address
Rugvaenget 5, Ansager, DNK, DK-6823
DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.

DanCann Pharma AS Headlines

No Headlines